Light Mode
$0.8690 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.8690, $0.1709 below the day’s high of $1.0399
-3.63 (-80.69%) / 6M
Momentum, market sentiment, and recent alerts
RADX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -82.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company was founded by Paul A. Hopper in 2021 and is headquartered in Carlton, Australia.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.